Foresite Capital Management IV as of Dec. 31, 2020
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 13 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 41.8 | $385M | 9.7M | 39.78 | |
| Keros Therapeutics (KROS) | 10.8 | $100M | 1.4M | 70.54 | |
| Relay Therapeutics (RLAY) | 9.7 | $89M | 2.1M | 41.56 | |
| Alx Oncology Hldgs (ALXO) | 9.1 | $84M | 974k | 86.20 | |
| Nurix Therapeutics (NRIX) | 8.4 | $77M | 2.3M | 32.88 | |
| Kura Oncology (KURA) | 6.4 | $59M | 1.8M | 32.66 | |
| Olema Pharmaceuticals (OLMA) | 4.3 | $39M | 818k | 48.08 | |
| Cytokinetics (CYTK) | 3.2 | $30M | 1.4M | 20.78 | |
| Generation Bio (GBIO) | 2.6 | $24M | 858k | 28.35 | |
| Vaxcyte (PCVX) | 1.3 | $12M | 466k | 26.57 | |
| Cymabay Therapeutics | 1.1 | $10M | 1.8M | 5.74 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $6.2M | 951k | 6.47 | |
| Therapeutics Acquisition Corp Com Cl A | 0.5 | $4.9M | 350k | 13.92 |
